Skip to content

Uta Griesenbach, Professor of Molecular Medicine, National Heart and Lung Institute Imperial College London

Uta is a Professor of Molecular Medicine and has over 25 years experience in developing advanced therapeutics. Her research interests are related to the development of gene therapy for cystic fibrosis (CF) and other lung diseases. She has overseen vector and biomarker development, toxicology studies, as well as vector manufacturing and has been a Co-I on several clinical trials. Uta is a member of the UK Respiratory Gene Therapy Consortium (GTC) strategy group, Co-director of the Imperial Centre for Excellence in Advanced Therapies, a Co-founder of AlveoGene (Imperial College Spinout) and a Non-executive director of the Cell and Gene Therapy Catapult. In addition to her research activities, she has an active role in education and workforce development related to advanced therapeutics in the UK.